The effect of hyperthermia on mitomycin-C induced cytotoxicity in four human bladder cancer cell lines

European Urology

Volumn 46, Issue 5, 2004, Pages 670-674

  Van Der Heijden, Antoine G ^a   Jansen, Cornelius F J ^a   Verhaegh, Gerald ^a   O'Donnell, Michael A ^b   Schalken, Jack A ^a   Witjes, J Alfred ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

Bladder cancer cell line; Cytotoxicity; Hyperthermia; Mitomycin C; MTT assay

Indexed keywords

MITOMYCIN C; MUTANT PROTEIN; PROTEIN P53; TETRAZOLIUM; THIAZOLE;

ADDITION REACTION; AQUEOUS SOLUTION; ARTICLE; BLADDER CANCER; CANCER CELL CULTURE; CELL KILLING; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOTOXICITY; DRUG EFFECT; GENE MUTATION; HUMAN; HUMAN CELL; HYPERTHERMIA; INCUBATION TIME; INTERMETHOD COMPARISON; PRIORITY JOURNAL; REACTION ANALYSIS; SPECTRAL SENSITIVITY; SPECTROSCOPY; STATISTICAL SIGNIFICANCE; TITRIMETRY;

ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; MITOMYCIN; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 5144226523     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.06.009     Document Type: Article

References (21)

1. Coley WB, The treatment of malignant tumors by repeated inoculations of erysipelas with a report of 10 original cases, Am J Med Sci 1891 488-511.
2. Hall R.R., Schade R.O., Swinney J. Effects of hyperthermia on bladder cancer. Br. Med J. 2:1974;593-594
3. Matzkin H., Rangel M.C., Soloway M.S. In vitro study of the effect of hyperthermia on normal bladder cell line and on five different transitional cell carcinoma cell lines. J Urol. 147:1992;1671-1674
4. Colombo R., Da Pozzo L.F., Lev A., Freschi M., Gallus G., Rigatti P. Neoadjuvant combined microwave induced local hyperthermia and topical chemotherapy versus chemotherapy alone for superficial bladder cancer. J. Urol. 155:1996;1227-1232
5. Colombo R., Brausi M., Da Pozzo L., Salonia A., Montorsi F., Scattoni V., et al. Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication. A pilot study on marker lesion. Eur. Urol. 39:2001;95-100
6. Booth C., Harnden P., Trejdosiewicz L.K., Scriven S., Selby P.J., Southgate J. Stromal and vascular invasion in an human in vitro bladder cancer model. Lab Invest. 76:1997;843-857
7. Davies G., Jiang W.G., Mason M.D. Cell-cell adhesion molecules and their associated proteins in bladder cancer cells and their role in mitogen induced cell-cell dissociation and invasion. Anticancer Res. 19:1999;547-552
8. Elliott A.Y., Bronson D.L., Cervenka J., Stein N., Fraley E.E. Properties of cell lines established from transitional cell cancers of the human urinary tract. Cancer Res. 37:1977;1279-1289
9. Cooper M.J., Haluschak J.J., Johnson D., Schwartz S., Morrison L.J., Lippa M., et al. p53 mutations in bladder carcinoma cell lines. Oncol. Res. 6:1994;569-579
10. Hahn G.M., Li G.C. Interactions of hyperthermia and drugs: treatments and probes. Natl. Cancer Inst. Monogr. 61:1982;317-323
11. Cavaliere R., Ciocatto E.C., Giovanella B.C., Heidelberger C., Johnson R.O., Margottini M., et al. Selective heat sensitivity of cancer cells. Biochemical and clinical studies. Cancer. 20:1967;1351-1381
12. Colombo R., Da Pozzo L.F., Salonia A., Rigatti P., Leib Z., Baniel J., et al. Multicentric study comparing intravesical chemotherapy alone and with local microwave hyperthermia for prophylaxis of recurrence of superficial transitional cell carcinoma. J Clin. Oncol. 21:2003;4270-4276
13. van der Heijden A.G., Kiemeney L.A., Gofrit O.N., Nativ O., Sidi A., Leib Z., et al. Preliminary European results of local microwave hyperthermia and chemotherapy treatment in intermediate or high risk superficial transitional cell carcinoma of the bladder. Eur. Urol. 46:2004;65-72
14. Paroni R., Salonia A., Lev A., Da Pozzo L.F., Cighetti G., Montorsi F., et al. Effect of local hyperthermia of the bladder on mitomycin C pharmacokinetics during intravesical chemotherapy for the treatment of superficial transitional cell carcinoma. Br. J. Clin. Pharmacol. 52:2001;273-278
15. Van Bree C., Beumer C., Rodermond H.M., Haveman J., Bakker P.J. Effectiveness of 2′,2′difluorodeoxycytidine (Gemcitabine) combined with hyperthermia in rat R-1 rhabdomyosarcoma in vitro and in vivo. Int. J Hyperthermia. 15:1999;549-556
16. Dulic V., Kaufmann W.K., Wilson S.J., Tlsty T.D., Lees E., Harper J.W., et al. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023
17. Waga S., Hannon G.J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA. Nature. 369:1994;574-578
18. Caelles C., Helmberg A., Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature. 370:1994;220-223
19. Guan J., Stavridi E., Leeper D.B., Iliakis G. Effects of hyperthermia on p53 protein expression and activity. J Cell Physiol. 190:2002;365-374
20. Hainaut P., Butcher S., Milner J. Temperature sensitivity for conformation is an intrinsic property of wild-type p53a. Br. J Cancer. 71:1995;227-231
21. van Bree C., van der M.B., Ceha H.M., Franken N.A., Haveman J., Bakker P.J. Inactivation of p53 and of pRb protects human colorectal carcinoma cells against hyperthermia-induced cytotoxicity and apoptosis. J Cancer Res. Clin. Oncol. 125:1999;549-555